**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 87-65-0 |2,6-Dichlorophenol | >97 | 201-761-3 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water fog, dry chemical, carbon dioxide, or regular foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Avoid breathing dust.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 87-65-0:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: 0.036 mm Hg @ 25 deg C
Viscosity: Not available.
Boiling Point: 218-220 deg C @ 760mmHg
Freezing/Melting Point: 65-68 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C6H4Cl2O
Molecular Weight: 163.00
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Acid chlorides - acid anhydrides - oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 87-65-0: SK8750000
LD50/LC50:
CAS# 87-65-0: Draize test, rabbit, eye: 250 ug/24H Severe; Draize
test, rabbit, skin: 2 mg/24H Severe; Oral, mouse: LD50 = 2120 mg/kg;
Oral, mouse: LD50 = 2120 mg/kg; Oral, rat: LD50 = 2940 mg/kg.
Carcinogenicity:
2,6-Dichlorophenol -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: CHLOROPHENOLS, SOLID
Hazard Class: 6.1
UN Number: 2020
Packing Group: III
IMO
Shipping Name: CHLOROPHENOLS, SOLID
Hazard Class: 6.1
UN Number: 2020
Packing Group: III
RID/ADR
Shipping Name: CHLOROPHENOLS, SOLID
Hazard Class: 6.1
UN Number: 2020
Packing group: III
USA RQ: CAS# 87-65-0: 100 lb final RQ; 45.4 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/38 Irritating to eyes and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
WGK (Water Danger/Protection)
CAS# 87-65-0: No information available.
Canada
CAS# 87-65-0 is listed on Canada's NDSL List.
CAS# 87-65-0 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 87-65-0 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 2/20/1998 Revision #3 Date: 9/23/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2,6-Pyridinedicarboxylic Acid Chloride, 97%
| 3739-94-4 |
|
OPD tablets, 120 mg/tablet
| 615-28-1 |
|
Tetrabutylphosphonium bromide, 98%
| 3115-68-2 |
|
2'-Deoxyguanosine 5'-Monophosphate, Sodium Salt Hydrate
| 52558-16-4 |
|
4-(Dimethylamino)pyridinium Bromide Perbromide
| 92976-81-3 |
|
Mercury(ii) thiocyanate, p.a.
| 592-85-8 |
|
Beta-Ionone, Synthetic, 96%
| 14901-07-6 |
|
Quercetin (Pract)
| 117-39-5 |
|
4-Chlorobenzotrichloride, 99%
| 5216-25-1 |
|
1-Iodopropane, 99%, Stabilized over Copper
| 107-08-4 |
|
2-Acetyl-1-methylpyrrole, 99%
| 932-16-1 |
|
4-Dimethylamino-4'-nitrostilbene
| 4584-57-0 |
|
Pentafluorothiophenol, 97%
| 771-62-0 |
|
1-(4-METHOXYPHENYL)-1-CYCLOPROPANE- CARBONITRILE
| 16728-00-0 |
|
Triphenylthioantimonate, 99%
| 28609-58-7 |
|
4-Methylthiazole, 99%
| 693-95-8 |
|
DL-2-Amino-1-Propanol, 98%
| 6168-72-5 |
|
2,5-Diphenyl-p-benzoquinone (pract), 93% (uv-vis)
| 844-51-9 |
|
4-Methylbenzyltriphenylphosphonium chloride, 99%
| 1530-37-6 |
|
L-(+)-Prolinol
| 23356-96-9 |
|
Prostaglandin VIII, 99%
| 0-01-1 |
|
Allyl alcohol
| 107-18-6 |
|
Phosphorus Tribromide, 99%
| 7789-60-8 |
|
5-Nitroisoquinoline, 98%
| 607-32-9 |
|
1,3-Acetonedicarboxylic acid, 96%
| 542-05-2 |
|
Pentacene, 98%
| 135-48-8 |
|
3,3'-Dimethoxybenzidine dihydrochloride, 99% (titr.)
| 20325-40-0 |
|
Diethyl Bis(hydroxymethyl)malonate, 95% (HPLC)
| 20605-01-0 |
|
P-Bromo-DL-Phenylalanine, 99%
| 14091-15-7 |
|
1,2-(Didodecyloxy)benzene, 98% (GC)
| 42244-53-1 |
|
p-Anisaldehyde, 99+%
| 123-11-5 |
|
Diazogen, 99%
| 80-11-5 |
|
2-Fluoro-4-Nitrotoluene, 98%
| 1427-07-2 |
|
Sodium triacetoxyborohydride
| 56553-60-7 |
|
Indole-2-carboxylic acid, 99%
| 1477-50-5 |
|
Pyridoxine Hydrochloride, 99% (Titr.)
| 58-56-0 |
|
2,6-Dichlorophenol
| 87-65-0 |
|
1,2-Butanediol, 98%
| 26171-83-5 |
|
2-(2-Aminoethoxy)ethanol, 98%
| 929-06-6 |
|
Poly(propylene Glycol), Average M.W. 425
| 25322-69-4 |
|
Valinomycin, 96% (HPLC)
| 2001-95-8 |
|
7-Amino-4-Methyl-1,8-Naphthyridin-2-ol, 98 %
| 1569-15-9 |
|
Benzyl butyrate, 98%
| 103-37-7 |
|
Lutetium oxide, 99.99%, -325 mesh
| 12032-20-1 |
|
P-Nitrophenyl Chloroformate, 96% (Titr.)
| 7693-46-1 |
|
Potassium sorbate, 99%
| 590-00-1 |
|
Phthalan, 97%
| 496-14-0 |
|
Cinnamyl Acetate, 99+%
| 103-54-8 |
|
Butyl Isocyanatoacetate, 98% (GC)
| 17046-22-9 |
|
Zirconyl(IV) chloride octahydrate, 98+%
| 7699-43-6 |
|
|